p53 Mutations in Barrett's adenocarcinoma and high-grade dysplasia
Authors:
- Carissa A. SanchezCSCarissa A. Sanchez
- Patricia C. GalipeauPGPatricia C. Galipeau
- Patricia L. BlountPBPatricia L. Blount
- Douglas S. LevineDLDouglas S. Levine
- Geoff JoslynGJGeoff Joslyn
- Brian J. ReidBRBrian J. Reid
- 1 June 1994
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 106 (6) , 1589-1595
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Endoscopic biopsy technique for acquiring larger mucosal samplesGastrointestinal Endoscopy, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Barrett's EsophagusNew England Journal of Medicine, 1986
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976